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Background: Preoperative alcohol and other recreational substance use (ORSU)
may catalyze perioperative complications. Accordingly, interventions aiming to reduce
preoperative substance use are warranted.
Methods: Studies investigating interventions to reduce alcohol and/or ORSU in
elective surgery patients were identified from: Cochrane Library; MEDLINE; PSYCINFO;
EMBASE; and CINAHL. In both narrative summaries of results and random effects
meta-analyses, effects of interventions on perioperative alcohol/ORSU, complications,
mortality and length of stay were assessed.
Primary Results: Nine studies (n = 903) were included. Seven used behavioral
interventions only, two provided disulfiram in addition. Pooled analyses found small
effects on alcohol use (d: 0.34; 0.05–0.64), though two trials using disulfiram (0.71;
0.36–1.07) were superior to two using behavioral interventions (0.45; −0.49–1.39). No
significant pooled effects were found for perioperative complications, length of hospital
stay or mortality in studies solely targeting alcohol/ORSU. Too few interventions targeting
ORSU (n = 1) were located to form conclusions regarding their efficacy. Studies were
generally at high risk-of-bias and heterogeneous.
Conclusions: Preoperative interventions were beneficial in reducing substance use in
some instances, but more high-quality studies targeting alcohol/ORSU specifically are
needed. The literature to date does not suggest that such interventions can reduce
postoperative morbidity, length of hospital stay or mortality. Limitations in the literature
are outlined and recommendations for future studies are suggested.
Keywords: alcohol consumption, illicit drugs, perioperative care, postoperative complications, preoperative
period, substance-related disorder
INTRODUCTION
Up-to one in four adults in England drink hazardously, with up to 6% being alcohol dependent
(Health Social Care Information Centre, 2015). Up-to 5% of people aged 16–59 (9.1% of 16–24
years old) use an illicit substance at least monthly (Home Office, 2015). The prevalence of these
behaviors may be higher in elective surgical patients, particularly for alcohol: ∼20% of elective
Budworth et al. Preoperative Interventions: Substance Use
surgical patients show features of alcohol dependency (Harris
et al., 2008, 2011; Kip et al., 2008; Kleinwächter et al., 2010;
Bradley et al., 2011) and 7.5%-20% of elective patients admit
using other recreational substances at least once per year (up-to
26.4% of 18–30 years-old) (Kleinwächter et al., 2010; Kork et al.,
2012).
Preoperative alcohol overuse is deleterious to surgical
outcomes, with a 56% increase in postoperative general
morbidity observed in a meta-analysis comparing risky alcohol
users (defined as >36 grams per day of alcohol) vs. abstainers or
non-risky users (studies including patients with “clearly defined
heavy drinking” showed a 168% increased risk of mortality)
(Eliasen et al., 2013). The specific adverse effects of excessive
perioperative alcohol use include biochemical and hematological
abnormalities (even in the absence of liver disease), altered
drug kinetics and acute withdrawal (Chapman and Plaat,
2009). Preoperative use of other recreational substances (ORSU)
has also been shown to be detrimental, though evidence is
nascent: cannabis can potentiate or antagonize anesthetic drugs,
presenting considerable risks (Dickerson, 1980; Mallat et al.,
1996; Symons, 2002; White, 2002; Kuczkowski, 2004; Sharma
et al., 2012); cocaine and amphetamine present cardiovascular
issues (including intraoperative deaths) (Samuels et al., 1979;
Steadman and Birnbach, 2003; Inouye et al., 2004; Skerman, 2005;
Perruchoud and Chollet-Rivier, 2008; Baxter and Alexandrov,
2012; Elkassabany et al., 2013); and opioid users vs. non-users,
independent of various comorbidities and surgical procedures,
have up-to four times the odds of dying and two times the
odds of suffering any morbidity in the perioperative period
(Menendez et al., 2015). Lastly, a myriad of novel psychoactive
substances have flooded the European market, many of which
are demonstrably easy to acquire (e.g., legally) (Martinotti et al.,
2015). The pharmacokinetic profile of many are unknown which
may present potentially unpredictable risks and challenges for
perioperative management.
For tobacco smoking it has been demonstrated that
interventions to support patients in quitting are effective
at modifying surgical outcomes (Theadom and Cropley, 2006;
Thomsen et al., 2014). Intervention components, delivery, modes
and contexts have also been studied, showing that intervention
efficacy may be optimized by the use of specific behavior
change techniques and other intervention characteristics
(Prestwich et al., 2017). Reducing alcohol use from four, to two
standard drinks a day may reduce the incidence of perioperative
complications by up-to 50% (Tønnesen et al., 2009). Prolonged
bleeding time and surgical stress responses may be reversed
by an abstinence period of 4 weeks (Tønnesen et al., 2009).
While there are no similar guidelines for ORSU, preoperative
abstinence or reduction in use could arguably incur similar
benefits. Both alcohol and ORSU may thus be modifiable risk
factors for poor surgical outcomes. Consequently, interventions
aimed at supporting surgical patients to modify their use are
warranted, to protect patients and reduce healthcare costs (Scott
et al., 2005).
Two previous reviews of preoperative interventions
addressing alcohol use have shown that interventions may
be effective at reducing drinking in surgical patients (Oppedal
et al., 2012; Fernandez et al., 2015). However, the first had
very strict inclusion criteria (e.g., including only randomized
controlled trials), limiting the scope of the review, and undertook
their literature search in 2011. The second included only
behavioral interventions (excluding pharmaceutical support),
undertook their literature search in 2013, and did not calculate
pooled effects. To our knowledge, there have been no previous
reviews assessing the efficacy of preoperative interventions for
ORSU (e.g., cannabis, cocaine and/or opioid use). Additionally,
psychological determinants (e.g., motivation to abstain) of
alcohol and/or ORSU in the surgical context, and details of
how users may be supported in behavior change, have not been
described in sufficient detail in previous reviews.
In this review, we aimed to update previous alcohol
intervention reviews and identify characteristics of effective
(or ineffective) interventions. We also systematically review
the literature on ORSU interventions, assessing quantitative
evidence of their efficacy or otherwise at reducing substance use,
and/or perioperative complications. Thirdly, we assess whether
interventions could modify psychological determinants which
may predict cessation; and lastly, try to characterize intervention
components of any behavioral interventions using a behavior
change taxonomy (Michie et al., 2013), so future researchers can
more precisely replicate successful interventions.
METHODS
Search Strategy
The Cochrane Library, PSYCINFO, EMBASE, MEDLINE,
and CINAHL were searched up to November 2015. An
additional scoping search was conducted in April 2017. Terms
included “alcohol use,” and “preoperative care” (seeAppendix 1).
Additional studies were located via hand searching reference lists
of included studies and relevant narrative reviews. Titles and
abstracts were screened for eligibility by one reviewer, before a
random sample (n = 200) were screened by two others side-by-
side with open discussion (high level of agreement [k = 0.87]).
Disagreements were resolved through open discussion. Full-texts
of potential studies were inspected by two reviewers, with full
agreement regarding their eligibility.
Eligibility and Inclusion
Interventions targeting (i) alcohol and/or ORSU in the
preoperative period (with or without postoperative maintenance
sessions), and/or (ii) cognitive/behavioral determinants of
alcohol and/or ORSU in (iii) elective patients only, were included.
Any designs, surgical populations, and comparator groups (or
lack thereof) were eligible.
Primary Outcomes
(1) Level (e.g., amount, frequency) and/or severity (e.g.,
dependence scores) of alcohol and/or ORSU at any time
point (pre-surgery and/or post-surgery);
(2) Perioperative: mortality (at any postoperative time-point),
total complications (as defined by individual studies – at any
postoperative time-point), and length of hospital stay (days);
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(3) Measures of psychological determinants of perioperative
substance use (e.g., self-efficacy at reducing preoperative
substance use).
Secondary Outcomes
(1) Other outcomes idiosyncratic to each study deemed
clinically relevant, e.g., patient satisfaction, and quality of life.
Risk-Of-Bias and Data Extraction
Risk-of-bias was assessed using the Cochrane Collaboration
risk-of-bias assessment tool (Higgins et al., 2011). While it is
acknowledged that other tools are often used to assess non-
RCT designs, we felt it appropriate to appraise all studies against
desired gold standard research methods. For all studies, risk-
of-bias and data for primary and secondary outcomes, patient
demographics, retention rates and study design features were
single coded before being checked by a member of the review
team. There was full agreement.
Behavior change techniques (BCTs) (Michie et al., 2013)
targeted at alcohol or ORSU were coded by two authors to
determine intervention components. Disagreements were
resolved via discussion. Many intervention were poorly
described. Studies with ambiguous descriptions of intervention
components were coded “social support (unspecified)” (BCT 3.1)
while BCTs for one intervention (Weinrieb et al., 2011) and all
control groups were not coded due to insufficient reporting.
BCTs outlined in this report, therefore, should be considered
approximate.
Statistical Analysis
Comprehensive Meta-Analysis (Borenstein et al., 2009) was used
to compute, and where possible, pool effect sizes. Cohen’s d was
used as the effect size metric. For within-subjects outcomes, d> 0
favored post-intervention, d < 0 vice versa. For between-subjects
outcomes, d > 0 favored intervention patients vs. controls, d < 0
vice versa.
Effect sizes were based on reported means and standard
deviations, events in each group, or other statistical information,
such as t or p-values. For some outcomes, it was not possible to
calculate pre- to post-intervention between-subjects effect sizes.
In these cases, post-intervention data were used. Unadjusted data
were used where possible.
If outcomes were assessed at various time points, d for each
was calculated—in addition to the average d across time points
(pooling all in a within-study random effects meta-analysis). For
studies using various measures for a related outcome, d for these
measures were calculated individually—as well as the pooled
d across them (pooled in a within-study random effects meta-
analysis)—providing measure-specific d, and overall outcome-
specific d.
Random effects meta-analyses were used to pool data for the
primary outcomes (where possible). For each primary outcome
with at least two studies, all studies were first meta-analyzed,
before a series of sensitivity analyses investigated the results
further—accounting for unique trial features. Only between-
subjects data were used. The average d across within-study time
points andmeasures assessing a related outcome were entered for
each study (as detailed above). Homogeneity Q and I2 statistics
assessed heterogeneity.
Though planned, the number of studies found was not
sufficient to conduct metaregression assessing whether between-
study intervention efficacy could be predicted from the use of
different BCTs and certain design features.
RESULTS
Characteristics of the Included Studies
From 8,688 studies identified, nine were eligible (Figure 1): five
randomized controlled trials (Tønnesen et al., 1999; McHugh
et al., 2001; Tønnesen, 2002; Kummel et al., 2008; Weinrieb
et al., 2011) two non-randomized controlled trials (Shourie et al.,
2006; Hansen et al., 2012) one pre- to post-intervention study
(Ashton et al., 2013) and one mixed design study (Wyman
et al., 2014) (which compared some outcomes between a control
group [CG] and an intervention group [IG] and some within
the IG only). Two studies targeted the use of alcohol and other
recreational substances (Ashton et al., 2013; Wyman et al., 2014),
the rest alcohol use only. Three studies aimed to modify other
behaviors in conjunction with alcohol use e.g., exercise and
smoking (McHugh et al., 2001; Kummel et al., 2008; Hansen
et al., 2012). Five studies aimed to assess whether intervention
could alter perioperative health outcomes (Tønnesen et al., 1999;
Tønnesen, 2002; Shourie et al., 2006; Hansen et al., 2012; Wyman
et al., 2014). See Table 1 for study characteristics, Table 2 for
outcomes measures/results.
Across the studies, patients were awaiting various surgical
procedures (e.g., liver transplant, colorectal and coronary bypass
surgeries). Sample sizes ranged from 28 to 174 (total: 903), with
a large gender bias (∼72% male). Six studies did not report
patients’ ethnicity, of three that did (Weinrieb et al., 2011; Ashton
et al., 2013; Wyman et al., 2014) the majority were white (69%).
All patients were adults.
Five studies delivered multi-session interventions (Tønnesen
et al., 1999; McHugh et al., 2001; Tønnesen, 2002; Kummel et al.,
2008) (the rest one session only) and three (Kummel et al., 2008;
Ashton et al., 2013; Wyman et al., 2014) involved group (as
opposed to one-on-one) interventions. In three studies (McHugh
et al., 2001; Kummel et al., 2008; Hansen et al., 2012) the
intervention was delivered by nurses, in four (Tønnesen et al.,
1999; Tønnesen, 2002; Shourie et al., 2006; Weinrieb et al., 2011)
by amember of the research group, one (Wyman et al., 2014) with
multiple interventionists (psychologist, social worker or nurse),
and one (Ashton et al., 2013) a psychologist. All studies described
a motivational or general psychosocial behavioral intervention of
some sort, but none described their intervention in terms of a
behavior change technique taxonomy (that is, the interventions
may not have been standardized). In addition to “motivational
counseling” Tønnesen (2002) prescribed 800mg of disulfiram a
week (400mg taken under supervision, 400mg unsupervised), B
vitamins and offered chlordiazepoxide for withdrawal symptoms.
Tønnesen et al. (1999) had patients receive 800mg of disulfiram
weekly (other support unspecified).
Six studies (Tønnesen et al., 1999; McHugh et al., 2001;
Tønnesen, 2002; Shourie et al., 2006; Kummel et al., 2008;
Hansen et al., 2012) reported that controls received treatment
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as usual or routine care. Weinrieb et al. (2011) reported that
controls received treatment as usual plus referral to community
Alcoholics Anonymous and “standard intensive outpatient
therapy”; Wyman et al. (2014) that controls were informed that
they were at high-risk due to their substance use and were advised
to reduce or cease alcohol use. Ashton et al. (2013) did not
have a CG.
Risk-Of-Bias
Judgments can be seen in Figure 2.
Random Sequence Generation
Four studies (Shourie et al., 2006; Hansen et al., 2012; Ashton
et al., 2013; Wyman et al., 2014) were deemed at high
risk of bias as they did not use randomized designs. Three
randomized studies (McHugh et al., 2001; Kummel et al.,
2008; Weinrieb et al., 2011) were deemed at an unclear risk
as they did not report how the randomization sequence was
generated.
Allocation Concealment (Selection Bias)
All apart from two studies (Tønnesen et al., 1999; Tønnesen,
2002) data were deemed at high risk as they did not conceal
allocations.
FIGURE 1 | Flow diagram of the screening process.
Blinding of Patients and Personnel (Performance
Bias)
All studies were deemed at high risk of bias. Given the nature
of the interventions (all requiring some degree of face-to-face
contact), blinding was not achievable.
Blinding of Outcome Assessment (Detection Bias)
All did not report whether they (at minimum) blinded data
analysts, all were deemed high risk.
Incomplete Outcome Data (Attrition Bias)
One study (Kummel et al., 2008) was deemed as high risk because
no reasons for drop-outs were reported, the authors did not
mention how many dropped out between groups, and when
the authors compared drop-outs and non-drop-outs there were
significant differences in certain variables (e.g., females’ ages).
Selective Reporting (Reporting Bias)
All studies were stringently judged to be at high risk for selective
reporting. We made this decision on the basis that no pre-
registered protocol for any of the included studies could be found,
thus there was a chance that authors could have consciously
or unconsciously omitted any results inconsistent with their
hypotheses. To locate pre-registered studies, each study article
was checked for a passing reference or citation to a protocol, and
the reviewers also noted any protocols found in the database and
hand searches.
Other Bias
Six studies (Tønnesen et al., 1999; Tønnesen, 2002; Shourie et al.,
2006; Kummel et al., 2008; Weinrieb et al., 2011; Wyman et al.,
2014) were deemed at an unclear risk of bias due to a large
bias in recruited patient demographics. The decision of unclear
was made on the basis that it was unclear whether or how the
particular variables could bias the results.
Five studies (Tønnesen et al., 1999; Tønnesen, 2002; Shourie
et al., 2006; Weinrieb et al., 2011; Wyman et al., 2014) had a large
gender bias toward males, and one study (Kummel et al., 2008)
only recruited patients above 65 years-old.
RESULTS
Effect sizes across individual study outcomes are reported in
Table 2.
Alcohol Use
Individual Study Results (Seven Studies)
(1) Wyman et al. (2014): Large and significant reduction in
alcohol use disorder scores pre- to post-intervention (in
the IG only). In addition, 73.8% of the IG stated that they
reduced or stopped alcohol use before surgery and 64.8% up-
to follow-up. Though 9.1 and 17% reported no change in
their alcohol use before surgery and up-to follow-up. Zero
percent of participants said they would stop using alcohol
in the next 6 months, but 18.8% said they would reduce
their use. In contrast, 5.9% said they would increase use, and
24% continue to use the same amount. Many participants
reported that the questions were not applicable to them.
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FIGURE 2 | Risk-of-bias across individual studies.
(2) Kummel et al. (2008): Small beneficial effect for the IG over
CG at 3 months, but benefits for the CG over IG at 6 and
12 months, with an overall small and non-significant effect
size favoring controls—in relation to the between groups
proportion of patients reporting zero alcohol use, vs. use
more than once a week.
(3) McHugh et al. (2001): Non-significant, but moderate
(medium-sized effect) reduction in grams per week of
alcohol consumed in the IG vs. CG from baseline to 15-
months follow-up.
(4) Shourie et al. (2006): Moderate but non-significant reduction
in alcohol use disorder scores in the IG over CG from
baseline to 6-months follow-up. Small and non-significant
reduction in grams of alcohol consumed per day in the CG
over IG from baseline to follow-up. Non-significantly fewer
alcohol-dependent diagnosed CG patients between groups at
follow-up, with a small effect.
(5) Tønnesen et al. (1999): Moderately, but non-significantly,
more non-hazardous alcohol users in the IG vs. CG
at 1-month follow-up. Significantly fewer alcohol drinks
consumed weekly in the IG vs. CG at follow-up, with a large
effect.
(6) Tønnesen (2002): Very large and marginally significant
benefit for the IG over CG in regard to non-hazardous
drinking at 1-month follow-up. Significantly fewer grams per
week of alcohol consumed in the IG vs. CG at follow-up,
with a large effect—but not at 3-months follow-up, though
the effect was moderately large.
(7) Weinrieb et al. (2011): Up-to 108 weeks post-randomization
the IG consumed significantly fewer drinks, had significantly
fewer drinking days and consumed significantly fewer drinks
per drinking day vs. the CG, all with very large effect sizes
(but with wide confidence intervals). Fewer patients in the
CG drank before surgery vs. the IG, though the effect was
small and non-significant.
Meta-Analysis
A pooled analysis including all six studies (Tønnesen et al.,
1999; McHugh et al., 2001; Tønnesen, 2002; Shourie et al.,
2006; Kummel et al., 2008; Weinrieb et al., 2011) with between
groups alcohol outcomes significantly favored IGs, with a small to
moderate effect size (d: 0.34; 95% CI: 0.05–0.64; p= 0.02). There
was significant heterogeneity [I2 = 66%; Q(5) = 14.7, p= 0.01].
Separate pooled analyses were conducted for four trials using
behavioral interventions (McHugh et al., 2001; Shourie et al.,
2006; Kummel et al., 2008; Weinrieb et al., 2011), and the two
trials (Tønnesen et al., 1999; Tønnesen, 2002) using disulfiram
(as reported previously in Oppedal et al., 2012). Because
two of the behavioral-interventions i. did not have alcohol
use related inclusion criteria and ii. targeted multiple health
behaviors, we decided to conduct a pooled analysis without these
studies also.
Across behavioral intervention trials there was a very small,
non-significant effect on alcohol consumption [d: 0.14; 95%
CI:−0.13–0.41; p= 0.30; I2 = 45%; Q(3) = 5.5, p= 0.14]. In the
two behavioral trials with alcohol-related inclusion criteria there
was a moderate, but again, highly non-significant effect [d: 0.45;
95% CI: −0.49–1.39; p = 0.94; I2 = 70%; Q(1) = 3.3, p = 0.07].
In the two disulfiram trials there was a large significant effect
(d: 0.71; 95% CI: 0.36–1.07; p < 0.001) with little heterogeneity
[I2 = 0%; Q(1) = 0.22, p= 0.64].
Other Recreational Substance Use (ORSU)
Individual Study Results (Two Studies)
Only two studies considered ORSU. One study (Wyman
et al., 2014) explicitly aimed the intervention at other
recreational substance as well as alcohol use, another study
(Weinrieb et al., 2011) assessed ORSU in addition to alcohol
use, but it was unclear whether this was an intervention
target.
(1) Wyman et al. (2014): Large and significant reduction in the
number of patients reporting ORSU in the last 6 months
at follow-up (3-months post-surgery) vs. baseline (IG only).
Laboratory screening on the day of surgery found fewer
patients in the IG positive for ORSU vs. the CG (11 of the
IG [105 patients], 5 controls [56 patients]), though the effect
was small and non-significant.
(2) Weinrieb et al. (2011): No significant difference between
groups in regard to the number of patients using illicit
substances post-baseline (four of the IG [46 patients] and
three of the CG [45 patients]). There was a small effect
favoring the CG.
Meta-Analysis
After combining data from between-subjects outcomes in these
two studies, the pooled effect size was small, non-significant and
favored the IG [d: 0.12; 95% CI: −0.24–0.47; p = 0.52; I2 = 0%;
Q(1) = 0.47, p= 0.49].
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Psychological Determinants of Behavior
Individual Study Results (Two Studies)
Two studies assessed determinants of perioperative substance use
(see Table 2).
(1) Ashton et al. (2013): Large pre-post intervention increases
in patients’ knowledge of the deleterious effects of substance
use per se; the number of patients reporting that they were
“not likely” to return to drinking post-surgery; the number
of coping strategies patients could list to enable continuing
abstinence; the number of patients citing health reasons as
their primary motivation for abstinence.
(2) Weinrieb et al. (2011): IG significantly decreased in
ambivalence and recognition scores across time vs. the CG—
though, scores regarding taking steps did not show a change
across time. All three determinants relate to the likelihood of
engaging in and seeking out alcohol use treatment.
Perioperative Complications
Individual Study Results (Five Studies)
(1) Tønnesen et al. (1999): Significantly more CG patients
suffered any complication vs. those in the IG up-to 1 month
postoperatively, with a very large effect.
(2) Tønnesen (2002): Moderate to large benefit for the IG
over CG in relation to total complications up-to 1
month postoperatively, but no significant difference between
groups.
(3) Wyman et al. (2014): No significant difference in total
complications between groups during their hospital stay.
Non-significantly fewer cancellations or postponements in
surgery in the IG vs. CG (small effect). Non-significantly
more perioperative ICU admissions in the IG vs. CG (very
small effect).
(4) Hansen et al. (2012): No significant difference, but moderate
effect favoring the IG in total complications between-groups
up-to 3-months follow-up. Non-significantly fewer hospital
readmissions in the IG vs. CG up-to 3-months follow-
up with a small effect. Significantly more patients in the
CG vs. IG met hospital discharge criteria late (moderate
to large effect). Non-significantly more “unintended patient
pathways” (see Table 2) in the CG vs. IG, with a moderate
effect.
(5) Shourie et al. (2006): Significantly higher total number of
complications in the IG vs. CG up-to 5 days postoperatively,
with a moderately large effect. Non-significantly more
hospital admissions in the CG vs. IG in the previous 6
months with a small to moderate effect (at 6-months follow-
up).
Meta-Analysis
In a pooled analysis of all five studies assessing perioperative
complications, there was a non-significant effect favoring IGs,
with a small effect (d: 0.24; 95% CI: −0.26–0.73; p = 0.35).
There was significant heterogeneity [I2 = 74%; Q(4) = 12.3,
p= 0.004]. In total there were sixty-two complications in the IGs
(253 patients) and 67 in the CGs (235 patients).
A pooled analysis excluding Hansen et al. (2012) was
conducted for two reasons: i. the authors aimed to target a
number of health behaviors as well as alcohol (confounding
the potential beneficial effect of preoperative alcohol reduction),
and ii. because the authors only recruited four participants they
deemed hazardous alcohol users. The effect was again non-
significant and small [d: 0.21; 95% CI: −0.40–0.82; p = 0.50;
I2 = 78%; Q(3) = 13.8, p= 0.003].
Lastly, analyses were conducted separately (without Hansen
et al., 2012) for the two behavioral-intervention controlled
trials (Shourie et al., 2006; Wyman et al., 2014) and the two
disulfiram-based randomized controlled trials (Tønnesen et al.,
1999; Tønnesen, 2002) (as reported previously in Oppedal et al.,
2012). The latter found a large significant effect [d: 0.71; 95% CI:
0.36–1.07; p < 0.001; I2 = 0%; Q(1) = 0.2, p = 0.64], the former
a small non-significant effect [d: −0.23; 95% CI: −0.71–0.24;
p= 0.33; I2 = 61%; Q(1) = 2.6, p= 0.11].
Length of Hospital Stay
Individual Study Results (Four Studies)
(1) Tønnesen et al. (1999): Zero difference in length of
stay.
(2) Tønnesen (2002): Zero difference in length of stay.
(3) Shourie et al. (2006): Non-significantly fewer days in the
IG vs. CG with a small effect (a mean reduction of
1 day).
(4) Hansen et al. (2012): Significantly fewer days in the IG vs. CG
with a moderate effect (a median reduction of 1 day).
Meta-Analysis
Apooled analysis of all four studies significantly favored IGs, with
a small effect size [d: 0.27; 95% CI: 0.04–0.5; p= 0.02]. There was
low heterogeneity [I2 = 5%; Q(3) = 3.2, p= 0.37].
Again, a pooled analysis was conducted without Hansen et al.
(2012), this resulted in a small and non-significant effect [d: 0.12;
95% CI:−0.16–0.41; p= 0.41; I2 = 0%; Q(2) = 0.4, p= 0.82].
Mortality
Individual Study Results (Five Studies)
(1) Tønnesen et al. (1999): One death occurred in the IG, and
two in the CG up-to 1-month follow-up—a non-significant,
moderate effect favoring the IG.
(2) Tønnesen (2002): One death occurred in the total sample
(CG) up-to 1 month follow-up—a non-significant, moderate
to large effect favoring the IG.
(3) Shourie et al. (2006): One death occurred in each group up-
to 5 days post-surgery—a non-significant, small to moderate
effect favoring the CG.
(4) Hansen et al. (2012): Zero deaths per group up-to 3-months
follow-up.
(5) Rideout et al. (2012): Up-to 12 years post-randomization in
McHugh et al. (2001), there were 15 (50 patients) and 26
(60 patients) deaths in the IG and CG, respectively—a non-
significant, small effect favoring the IG (likely due to general,
not perioperative benefits of alcohol use reduction).
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Meta-Analysis
When considering perioperative mortality post-surgery (three
studies targeting alcohol use only: (Tønnesen et al., 1999;
Tønnesen, 2002; Shourie et al., 2006) the effect size was small and
non-significant (d: 0.21; 95% CI:−0.69–1.10; p= 0.65) with little
heterogeneity [I2 = 0%; Q(2) = 0.96, p = 0.62]. Across the three
studies there were two deaths in the IGs (126 patients), and in the
CGs four (79 patients). An additional study was not included in
this analysis as zero deaths were reported in either group up to 3
months post-surgery (Hansen et al., 2012).
The two disulfiram trials were pooled in a separate analysis.
Again, as reported previously in Oppedal et al. (2012), there was a
non-significant, moderately large benefit for IG patients with low
heterogeneity [d: 0.51; 95% CI: −0.59–1.60; p = 0.36; I2 = 0%;
Q(1) = 0.1, p = 0.77]. There were three deaths in the CGs (34
patients) and one death in the IGs (35 patients) up to 1-month
post-surgery.
Health Status/Health Related Quality of
Life
Individual Study Results (Five Studies)
Five studies (McHugh et al., 2001; Shourie et al., 2006; Kummel
et al., 2008; Weinrieb et al., 2011; Hansen et al., 2012) assessed
general health related outcomes.
(1) Hansen et al. (2012): Small non-significant improvement in
health-related quality of life in the IG vs. CG from baseline
to 3-months follow-up. Likewise for disease specific outcome
scores.
(2) McHugh et al. (2001): Average effect size across health-
related domains significantly much improved in the IG
over CG from baseline to 15-months follow-up. Large and
significant benefit for the IG in terms of both depression and
anxiety scores from baseline to follow-up. A range of physical
outcomes were improved in the IG vs. CG, including BMI,
and blood pressure from baseline to follow-up.
(3) Shourie et al. (2006): Small, non-significant benefits for
the IG in regard to the number of GP visits, and number
of days off work sick in the last 6 months, at 6-month
follow-up.
(4) Weinrieb et al. (2011): The authors report that there were no
significant differences across all time points for both groups
in relation to health-related quality of life and very little
difference in regard to depression and anxiety. Effect sizes
could not be calculated.
(5) Kummel et al. (2008): Average effect size for symptoms of
angina pectoris (not at all vs. at least once daily) across all
time points was very small and non-significantly favored the
CG. Across all time points, the IG reported significantly, but
moderately, better functional abilities vs. controls.
Patient Satisfaction
Individual Study Results (Three Studies)
Of three studies (McHugh et al., 2001; Ashton et al.,
2013; Wyman et al., 2014) assessing patient satisfaction,
all reported high patient satisfaction with the respective
interventions.
DISCUSSION
The present review primarily aimed to unite and update two
previous reviews (Oppedal et al., 2012; Fernandez et al., 2015)
of interventions for preoperative alcohol use, and for the
first time, systematically review the literature on preoperative
interventions for other recreational substance use (ORSU).
Identified were a small number of low-powered, high risk of
bias and demographically and methodologically heterogeneous
studies. Based on current evidence it cannot be concluded
that interventions may be delivered prior to patients’ surgery
to reduce ORSU, and certainly no one intervention strategy
can be recommended. Across individual studies, there was
some evidence that interventions can be delivered from pre-
to post-surgery to reduce alcohol consumption, though two
small trials using disulfiram (Tønnesen et al., 1999; Tønnesen,
2002) were far superior to trials of behavioral strategies alone.
Given small effects on alcohol consumption, there was no
evidence that preoperative interventions for alcohol or ORSU
could reduce the incidence of perioperative complications
on the whole, though again, Tønnesen et al. (1999) and
Tønnesen (2002) bucked this trend. Lastly, there were no clear
effects of interventions on mortality and length of hospital
stay in studies solely targeting alcohol use. Results, review
limitations and recommendations are respectively discussed
henceforth.
Summary of Results
Amajor finding of this reviewwas the lack of studies investigating
interventions for preoperative ORSU, despite evidence that
ORSU can impact on surgical outcomes. Wyman et al. (2014)
targeted ORSU (in addition to alcohol use), and Weinrieb et al.
(2011) assessed ORSU, but it was unclear whether ORSU was
targeted. While the former found that IG patients were less likely
to report using an illicit substance at follow-up vs. baseline (with
a very large effect), the absence of controls obfuscates any causal
relation the intervention may have had on ORSU. Furthermore,
responses were susceptible to social desirability biases given that
a non-validated, non-blinded self-report measure was used—
clearly evidenced by the fact that whilst the study did find that
more controls were positive for ORSU via objective screening
on the day of surgery, the effect was very small. In this
study, over 40% of patients had previously entered substance
use treatment, suggesting that patients were either current
or previously dependent recreational substance users. ORSU
dependency is notoriously difficult to treat, especially in the case
of opiates—speculatively, this short, one session intervention
may have been more effective with more casual users. More
intensive strategies may be necessary for those with dependency.
Again, while Weinrieb et al. (2011) found that controls were less
likely than intervention patients to be positive for ORSU, baseline
ORSU data was absent from the final publication and could not
be retrieved after correspondence with the authors. Given that the
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study primarily aimed to reduce alcohol use this is unsurprising.
Pooling both study’s between-group outcomes found a small and
non-significant benefit for the IGs, but more evidence is needed
to form substantial conclusions regarding the efficacy of ORSU
targeted interventions.
While there is more evidence to suggest interventions can be
delivered to reduce preoperative alcohol vs. ORSU, the evidence
is still not strong. A pooled analysis of all six studies investigating
this outcome has a small and significant effect, though the
confidence intervals were wide and studies heterogeneous.
Behavioral interventions showed to be largely ineffective on
the whole. Two behavioral intervention trials (Shourie et al.,
2006; Weinrieb et al., 2011) which included risky alcohol users
fared better, but this was to be expected given that these
interventions had primary a focus on alcohol use (as opposed
to multiple behaviors). Disulfiram trials (Tønnesen et al., 1999;
Tønnesen, 2002) were by far the most effective—both achieving
complete abstinence prior to surgery, and benefits up to 1
month post-surgery. However, these trials were both small, and
given dangerous side effects (e.g., neurotoxicity) and generally
low compliance (e.g., Fuller et al., 1986; Pettinati et al., 2008;
Kalra et al., 2014), disulfiram is a medication to be used with
caution and only in a small population of highly motivated,
alcohol dependent patients. There are however a number of
other pharmaceutical protocols, shown useful in similar contexts,
which may aid detoxification in the preoperative context, such as
those involving pregabalin and clomethiazole (Di Nicola et al.,
2010; e.g., Sychla et al., 2017).
As there were no significant overall effects on perioperative
complications, mortality and length of hospital stay, this may
be explained by intervention timing. Some studies neglected to
report the time from intervention to surgery, thus interventions
may have been delivered so close to surgery that any beneficial
effects could not have time to materialize. Furthermore, acute
cessation in risky alcohol users may incur withdrawal symptoms,
leading to counterproductive effects. In support, Shourie et al.
(2006), who did report time to surgery, and included risky alcohol
users only, found significantly more complications in the IG, but
had only a minimum of 1 week from intervention to surgery.
While two trials of disulfiram (Tønnesen et al., 1999; Tønnesen,
2002) appeared superior to two behavioral trials for perioperative
complications, this may be explained by length of follow-up.
While Tønnesen et al. (1999) and Tønnesen (2002)) assessed
between group complications up to 1 month post-surgery,
Wyman et al. (2014) and Shourie et al. (2006) only assessed
intraoperative and immediate post-surgical complications. It
is well-known that many complications may only emerge in
the postoperative recovery period, thus these studies may have
missed any between group differences in recovery. Lack of
complications in the immediate postoperative period may also
explain lack of differences in length of hospital stay across all
studies—and as is likely in the case of mortality, may be a result of
small sample sizes, and thus lack of power. Lastly, the fact that the
disulfiram trials both achieved complete preoperative abstinence
as opposed to be moderate reductions in alcohol use in both
behavioral trials, more than likely had beneficial implications for
surgical complications.
One study (Ashton et al., 2013) showed that an intervention
could boost patients’ intentions to reduce alcohol-use
post-surgery, increase their knowledge of the harms of
perioperative substance use, and increase the number of
coping strategies—to aid perioperative cessation—patients could
list. Though it is unclear whether this influenced their actual
behavior, medium to large effects on intentions may lead to
small to medium effects on behavior (Gollwitzer and Sheeran,
2006). Increased knowledge of harm may be associated with
lower alcohol consumption also (e.g., Thadani et al., 2009).
Another study (Weinrieb et al., 2011) found showed some
beneficial intervention effects on stages of change scores. This
is a positive finding as motivation to reduce alcohol use is a
predictor of an actual reduction in alcohol use (e.g., Kohler and
Hofmann, 2015). There were several methodological issues with
these studies however, as both studies were generally at high
risk-of-bias.
There were some positive intervention effects regarding other
outcomes. One study (McHugh et al., 2001) found intervention
benefits for BMI/cholesterol and general health, others quality of
life. Though all of these results may be confounded by targeting of
multiple health behaviors, another, exclusively alcohol-focussed
study (Weinrieb et al., 2011), found intervention benefits for
outcomes relating to general health.
All interventions that assessed patient satisfaction reported
high levels. Patients therefore may be receptive to behavior
change in the perioperative period. This may have positive
implications for patient retention within trials and may foster
patient acceptability and motivation. However, almost uniformly
high patient satisfaction may highlight another issue; those
recruited may represent only those most motivated, and thus
intervention efficacy may be artificially inflated. Indeed, it
took many studies over a year to recruit their participants,
and those agreeing may have been only those most receptive
to intervention. This is highlighted by an incredibly small
proportion (1.5%) of those approached being recruited in
Tønnesen (2002). Recruitment is clearly a challenge in this area,
with a relatively small total n of 903 across nine trials.
Review Limitations
The relative efficacy of behavioral interventions on preoperative
vs. postoperative alcohol use (or ORSU) use could not be
established—an important distinction, as complications, such
as prolonged bleeding time may be reversed by a preoperative
alcohol abstinence period of 4 weeks. Just one behavioral-only
intervention (Weinrieb et al., 2011) Assessed post-baseline, but
preoperative alcohol use, but did not assess complications—
so the causal relation between preoperative reduction or
abstinence and complications could not be delineated. As few
studies were identified, meta-regression analyses aiming to
assess whether retrospectively identified BCTs could predict
intervention efficacy could not be performed.
Across studies, no pre-published study protocols were found,
thus there was a risk of selective reporting; just five studies were
randomized, though just two (Tønnesen et al., 1999; Tønnesen,
2002) reported the method of sequence generation; no studies
were blinded in any way; and just two studies (again, Tønnesen
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et al., 1999; Tønnesen, 2002) concealed allocations. Many studies
had a large bias toward male patients, and one study (Kummel
et al., 2008) included patients over 65 only. Such biases may have
influenced the effect sizes across studies, so must be considered
when interpreting the results. Additionally, different surgical
populations have different prevalence rates of substance use
and different underlying conditions and procedures naturally
lead to different complication rates. Readers should be mindful
that the type of surgery may have impacted on both
substance use cessation rates and the number of complications
suffered.
There were a number of other potential moderators, such
as length of follow-up, and patient demographic variables (e.g.,
comorbidities). If more studies were available, subgroup analyses
would have been useful to investigate these. Publication bias
might account for some of the observed effects also. The number
of studies located was not sufficient to conduct a formal analysis
of this phenomenon.
Recommendations
For behavioral interventions, just one study cited a replicable
intervention protocol. For most studies, it was not explicit
what intervention techniques were used. Therefore, accurately
replicating successful interventions is difficult for future
researchers. In this review, behavior change techniques
(BCTs) were respectively identified—providing a non-
comprehensive indication of the techniques used, but the
above issues made the process difficult. Future studies
should aim to characterize BCTs, or at minimum, cite—or
describe in sufficient detail—intervention protocols. Further,
it is not clear whether any studies undertook appropriate
elicitation research—that is, systematically identified salient,
population-specific behavioral determinants. This is a vital
component of intervention development, ensuring that
intervention techniques are aimed at appropriate targets
and allowing researchers to link interventions with behavior
change theory (identifying interventions’ mechanisms of
action). Numerous guidelines exist (e.g., Michie et al., 2011)
for this process and researchers should be mindful of these
conventions.
Future studies should consider solely targeting alcohol or
ORSU, so that any confounding influence of changing other
behaviors on perioperative outcomes is minimized. Researchers
should also consider intervening on specific recreational
substances (an intervention may be useful at reducing cannabis,
but not heroin use). Researchers should aim to measure behavior
both preoperatively and postoperatively, to (i) assess whether
interventions can have differential effects between time periods,
and (ii) assess the causal relation between a preoperative
reduction in substance use and perioperative outcomes. The
number and length of intervention sessions, and the time from
intervention to surgery, should be reported also, as these may
be key moderators of intervention efficacy. Researchers may
also explore whether intervention efficacy is moderated by
patients’ surgical procedure, and the frequency and/or extent
of patients’ alcohol or ORSU. This may be achieved by having
inclusion criteria that limits the sample to those undergoing
specific surgeries, and those having varying levels of substance
use.
Given their diversity in this review, it would be useful
for researchers to standardize outcome measures, easing
comparisons between studies. Standardization may be achieved
by developing a substance-use specific core outcome set (see the
COMET initiative; Prinsen et al., 2014), alongside the current set
for postoperative complications generally (Jammer et al., 2015).
It would also be beneficial to include more patient-centered
outcomes, such as return to work, functioning and quality of life.
Similarly, objective measures for substance use are needed (e.g.,
urine and breath tests) to reduce recall and social desirability
biases.
Future studies should aim to minimize risk-of-bias and
improve on their designs. Though blinding is difficult with
behavioral interventions, blinding of assessors could be achieved.
Additionally, future studies should use randomized designs
with appropriate controls, report their random sequence-
generation method and pre-publish their protocols. Future
studies should provide formal power calculations to estimate
required sample sizes before recruitment, and therefore employ
larger sample sizes to identify between-group differences in
somewhat rare surgical complications. Studies should recruit
more representative samples, including a wider range of
patient ages, ethnicities and an equal distribution of both
sexes.
Conclusion
Despite limitations, we have identified important gaps in the
evidence base, Such as the small number of trials to reduce ORSU
versus alcohol use. Given the efficacy of the two small disulfiram
trials, prescribing this pharmaceutical may be useful for a small
subset of patients with alcohol dependency, though it may only be
appropriate for patients most at risk. For non-dependent heavy
alcohol users, the best strategy has yet to be identified—though
motivational strategies, and strategies targeted specifically at
alcohol use, marginally appear to be useful. Future studies would
benefit from higher quality designs and more standardization
in measures and inclusion criteria across the field. In the case
of behavioral interventions, more intervention development
work may be necessary. As more robust evidence accumulates,
more substantial recommendations for best practice may be
drawn.
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